Cresco Labs (CRLBF) EBITDA Margin Growth (1y) (2021 - 2026)
Cresco Labs (CRLBF) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn | -216.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -81.00 |
| Dec 31, 2025 | -7,036.00 |
| Sep 30, 2025 | -1,771.00 |
| Jun 30, 2025 | -770.00 |
| Mar 31, 2025 | -763.00 |
| Dec 31, 2024 | -553.00 |
| Sep 30, 2024 | 278.00 |
| Jun 30, 2024 | 2,300.00 |
| Mar 31, 2024 | 1,398.00 |
| Dec 31, 2023 | 1,428.00 |
| Sep 30, 2023 | 591.00 |
| Jun 30, 2023 | -1,582.00 |
| Mar 31, 2023 | -2,182.00 |
| Dec 31, 2022 | -1,133.00 |
| Sep 30, 2022 | -1,314.00 |
| Jun 30, 2022 | -1,129.00 |
| Mar 31, 2022 | -115.00 |
| Dec 31, 2021 | 767.00 |
| Sep 30, 2021 | -194.00 |
| Jun 30, 2021 | 2,257.00 |